ReGen files for bankruptcy despite $1m financing
This article was originally published in Clinica
Executive Summary
ReGen Biologics has filed for bankruptcy a week after US clearance for its knee implant, Menaflex, was rescinded by the FDA.
You may also be interested in...
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
MRM Health Pulls A Pouchitis Hit Out Of The Bag
The mid-stage success is encouraging, but taking on Takeda won’t be easy.
Novartis Draws Out Its APPLAUSE
Another data drop from Fabhalta’s IgAN trial looks encouraging, despite a missing abstract.